Greg Auclair, M.Sc. is a Sr. Director, Cardiovascular Medical Affairs at Cytokinetics, Inc. based in Sudbury, Massachusetts, United States, North America. With over 20 years of experience in the pharma, biotech, and medical device industries, I am a goal-oriented, results-driven, and culture-driven leader in marketing and medical affairs. I have a proven track record of building field medical affairs teams from the ground up, collaborating cross-functionally with marketing, sales, R&D, and clinical development, and planning and executing strategic initiatives. Currently, I am the Sr. Director of Cardiovascular Medical Affairs at Cytokinetics, a clinical stage biopharmaceutical company focused on developing therapies for patients with diseases of impaired muscle function. I have extensive knowledge and expertise in various therapeutic areas, including genetics / RNAi, orthopedics, renal denervation, heart failure, hypertension, hyperlipidemia, omega-3 fatty acids, and cardiology devices. I am passionate about advancing the science and practice of medicine, delivering innovative solutions for unmet medical needs, and developing strong rapport, communication, and advocacy with key opinion leaders and health care professionals.
Current Position: Sr. Director, Cardiovascular Medical Affairs
Company: Cytokinetics, Inc.
Location: Sudbury, Massachusetts, United States, North America
Social: Professional profiles available
Network: Extensive professional connections